Cargando…
IDELVION: A Comprehensive Review of Clinical Trial and Real-World Data
Hemophilia B is a bleeding disorder caused by a deficiency of coagulation factor IX (FIX). Treatment with FIX replacement products can increase FIX activity levels to minimize or prevent bleeding events. However, frequent dosing with standard-acting FIX products can create a high treatment burden. L...
Autores principales: | Escobar, Miguel, Mancuso, Maria Elisa, Hermans, Cedric, Leissinger, Cindy, Seifert, Wilfried, Li, Yanyan, McKeand, William, Oldenburg, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875492/ https://www.ncbi.nlm.nih.gov/pubmed/35207344 http://dx.doi.org/10.3390/jcm11041071 |
Ejemplares similares
-
High adherence to prophylaxis regimens in haemophilia B patients receiving rIX‐FP: Evidence from clinical trials and real‐world practice
por: Mancuso, Maria Elisa, et al.
Publicado: (2020) -
Imputing missing genotypes: effects of methods and patterns of missing data
por: Ogut, Funda, et al.
Publicado: (2011) -
Hemophilia A: Strategies for Improving Long-Term Holistic Management, Adherence, and Quality of Life
por: Escobar, Miguel A., et al.
Publicado: (2022) -
Real-world data in patients with congenital hemophilia and inhibitors: final data from the FEIBA Global Outcome (FEIBA GO) study
por: Ettingshausen, Carmen Escuriola, et al.
Publicado: (2023) -
Genomic selection in loblolly pine - from lab to field
por: Isik, Fikret, et al.
Publicado: (2011)